K. Uffelman

发表

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes.

I. Tkáč, G. Lewis, G. Steiner, 1998, Atherosclerosis.

Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals

G. Lewis, G. Steiner, K. Uffelman, 1993, Diabetes.

Postprandial lipoproteins and progression of coronary atherosclerosis.

A. Hamsten, F. Karpe, T. Olivecrona, 1994, Atherosclerosis.

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

G. Lewis, A. Carpentier, P. Barrett, 1999, The Journal of clinical investigation.

Lipolytically Modified Triglyceride-Enriched HDLs Are Rapidly Cleared From the Circulation

G. Lewis, K. Adeli, P. Barrett, 2002, Arteriosclerosis, thrombosis, and vascular biology.

VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin.

B. Zinman, G. Lewis, G. Steiner, 1994, The American journal of physiology.

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

G. Lewis, G. Steiner, K. Uffelman, 1995, The Journal of clinical investigation.

Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.

G. Lewis, P. Barrett, B. Lamarche, 1998, Journal of lipid research.

Fasting and Postprandial Overproduction of Intestinally Derived Lipoproteins in an Animal Model of Insulin Resistance

G. Lewis, K. Adeli, K. Uffelman, 2002, The Journal of Biological Chemistry.

The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism.

M. Vranic, G. Lewis, A. Carpentier, 2001, Diabetes.

Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.

G. Lewis, S. Lemieux, H. Duez, 2008, The Journal of clinical endocrinology and metabolism.

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states.

G. Lewis, K. Uffelman, S. Rashid, 2002, Journal of diabetes and its complications.

Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals.

G. Lewis, A. Carpentier, B. Patterson, 2005, Atherosclerosis.

Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins.

G. Lewis, S. Lemieux, G. Steiner, 1998, Journal of lipid research.

Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster*

G. Lewis, A. Carpentier, K. Adeli, 2002, The Journal of Biological Chemistry.

Expression of Human Hepatic Lipase in the Rabbit Model Preferentially Enhances the Clearance of Triglyceride‐Enriched Versus Native High‐Density Lipoprotein Apolipoprotein A‐I

D. Rader, G. Lewis, K. Uffelman, 2003, Circulation.

Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits.

P. Vicini, G. Lewis, K. Adeli, 2001, Journal of lipid research.

Clearance of postprandial and lipolytically modified human HDL in rabbits and rats.

G. Lewis, P. Barrett, B. Lamarche, 1997, Journal of lipid research.

The chromogenicity and quantitation of apoB-100 and apoB-48 of human plasma lipoproteins on analytical SDS gel electrophoresis.

G. Steiner, K. Uffelman, M. Poapst, 1987, Atherosclerosis.

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

B. Patterson, J. Davignon, G. Steiner, 2004, The Journal of clinical endocrinology and metabolism.

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster.

G. Lewis, K. Adeli, K. Uffelman, 2005, Endocrinology.

Vasopeptidase Inhibitor Omapatrilat Induces Profound Insulin Sensitization and Increases Myocardial Glucose Uptake in Zucker Fatty Rats: Studies Comparing a Vasopeptidase Inhibitor, Angiotensin-Converting Enzyme Inhibitor, and Angiotensin II Type I Receptor Blocker

J. Rouleau, G. Lewis, A. Giacca, 2003, Circulation.

Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans

G. Lewis, H. Duez, B. Lamarche, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Mechanism of HDL lowering in insulin resistant states.

G. Lewis, B. Lamarche, K. Uffelman, 2001, Advances in experimental medicine and biology.

Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone.

G. Lewis, K. Adeli, J. Brunzell, 2004, Diabetes.

Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters.

G. Lewis, K. Adeli, K. Uffelman, 2004, Endocrinology.

Effect of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals

G. Lewis, G. Steiner, K. Uffelman, 1993 .

Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men

G. Lewis, A. Carpentier, A. Giacca, 2004, Diabetologia.

Atorvastatin induces insulin sensitization in Zucker lean and fatty rats.

I. G. Fantus, G. Lewis, Chao-Hung Wang, 2006, Atherosclerosis.

Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance.

G. Lewis, K. Adeli, K. Uffelman, 2004, Atherosclerosis.

Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: studies before and after triglyceride-lowering therapy.

G. Getz, G. Lewis, B. Lamarche, 1998, Metabolism: clinical and experimental.

Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.

I. G. Fantus, G. Lewis, K. Uffelman, 2006, The Journal of endocrinology.

Effect of Atorvastatin on High-Density Lipoprotein Apolipoprotein A-I Production and Clearance in the New Zealand White Rabbit

G. Lewis, P. Barrett, K. Uffelman, 2002, Circulation.

Remnants and coronary artery disease progression

A. Hamsten, F. Karpe, T. Olivecrona, 1994 .

The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles.

I. Tkáč, G. Lewis, B. Kimball, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Lipids and lipoproteins in anorexia nervosa before and after partial weight restoration

S. Kennedy, G. Lewis, G. Steiner, 1994 .

Postprandial remnant-like lipoproteins in hypertriglyceridemia.

K. Nakajima, T. Ooi, G. Steiner, 2001, The Journal of clinical endocrinology and metabolism.